LJP-1586 HCl是一种高选择性的血管粘附蛋白-1（VAP-1）抑制剂，通过减少脑出血（ICH）后粘附分子表达和免疫细胞浸润而显示出抗炎作用。

LJP-1586 HCl, a highly selective inhibitor of vascular adhesion protein-1 (VAP-1), exhibits antiinflammation effect by reducing adhesion molecule expression and immune cell infiltration after intracerebral hemorrhage (ICH).

955037-42-0

C11H15ClFNO

231.69

LJP-1586 hydrochloride

H2O:40mg/mL,Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years